DaVita HealthCare Partners Inc. (DVA) experienced a significant after-hours surge of 9.79% following the release of its fourth-quarter financial results. The sharp upward movement occurred in post-market trading as investors reacted to the company's latest earnings report.
The dialysis services provider reported adjusted earnings per share of $3.40 for Q4 2025, surpassing the analyst consensus estimate of $3.16. Revenue for the quarter reached $3.62 billion, also exceeding expectations of $3.50 billion. The strong performance represents substantial year-over-year growth, with earnings increasing 51.79% from $2.24 per share in the same period last year.
Adding to the positive sentiment, DaVita provided an optimistic outlook for 2026, forecasting adjusted diluted net income from continuing operations in the range of $13.60 to $15.00 per share. This guidance significantly exceeds the analyst estimate of $12.82 per share, indicating management's confidence in the company's future performance and growth trajectory.
Comments